DOI: 10.1055/s-00000069

Seminars in Liver Disease

Referenz

TACE-2.
A randomized placebo-controlled, double blinded, phase III trial of sorafenib in combination with transarterial chemoembolization in hepatocellular cancer.
Available at:
http://clinicaltrials.gov/ct2/show/NCT01324076 . Accessed February 23, 2012

Bibliographische Angaben herunterladen

Suchen in: